Genocea Biosciences, Inc.
GNCA
GNCA was delisted on the 2nd of June, 2022.
47 hedge funds and large institutions have $143M invested in Genocea Biosciences, Inc. in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 6 closing their positions.
850% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 2
214% more capital invested
Capital invested by funds: $45.3M → $143M (+$97.3M)
150% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 6
24% more funds holding
Funds holding: 38 → 47 (+9)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$9.13M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.54M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$7.5M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$7.03M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$3.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.53M |
| 2 |
SGAM
Steinberg Global Asset Management
Boca Raton,
Florida
|
-$76K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$44.2K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$42.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8K |
GNCA Hedge Fund Activity: Q1 2015 in Review
47 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2015, worth a combined $143M — up 214% from $45.3M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new GNCA positions and 6 closed out — a net gain of 9 holders — while 19 added to existing stakes and 2 trimmed.
The largest buyer was Broadfin Capital, opening a new position worth an estimated $9.13M. The largest seller was Wellington Management Group, exiting entirely with an estimated $1.53M sold.
- 47 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q1 2015, up from 38 in Q4 2014.
- Funds reported $143M of Genocea Biosciences, Inc. stock for Q1 2015, up 214% quarter-over-quarter.
- 15 funds opened new Genocea Biosciences, Inc. positions in Q1 2015 and 6 closed out, a net change of +9 holders.
- The largest Genocea Biosciences, Inc. buyer in Q1 2015 was Broadfin Capital, an estimated $9.13M added.
- The largest Genocea Biosciences, Inc. seller in Q1 2015 was Wellington Management Group, an estimated $1.53M sold.
Based on aggregated 13F filings for Q1 2015.